Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

Presentation TCT 2024

TCT 765: Lipid-Lowering Therapy in Contemporary PCI Practice

Presenter: Patrick Serruys

October 30, 2024

Presentation TCT 2024

TCT 43: Definitions and Standardized Endpoints for the Use of Drug Coated Balloon in Coronary Artery Disease: Consensus Document of Drug Coated Balloon Academic Research Consortium

Presenter: Patrick Serruys

October 28, 2024

Presentation TCT 2024

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

Presenter: Patrick Serruys

October 28, 2024

Presentation TCT 2024

TCT 515: Myocardial Blood Flow Distribution Derived From CCTA, Myocardium at Risk, and Revascularization Completeness in FASTTRACK CABG

Presenter: Patrick Serruys

October 28, 2024

Presentation TCT 2024

Impact of Small or Non-Small Vessel Disease to Drug-Coated Balloon Angioplasty for the Treatment of De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial

Presenter: Patrick Serruys

October 27, 2024

Presentation TCT 2024

Full Circle: The Future is Uncaging the Vessel

Presenter: Patrick Serruys

October 27, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Daily News

New Machine Learning-Based Tool Predicts Individual Post-PCI Outcomes

Yael L. Maxwell

January 25, 2024

Advertisement

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

TCT 765: Lipid-Lowering Therapy in Contemporary PCI Practice

TCT 43: Definitions and Standardized Endpoints for the Use of Drug Coated Balloon in Coronary Artery Disease: Consensus Document of Drug Coated Balloon Academic Research Consortium

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

TCT 515: Myocardial Blood Flow Distribution Derived From CCTA, Myocardium at Risk, and Revascularization Completeness in FASTTRACK CABG

Impact of Small or Non-Small Vessel Disease to Drug-Coated Balloon Angioplasty for the Treatment of De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial

Full Circle: The Future is Uncaging the Vessel

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

New Machine Learning-Based Tool Predicts Individual Post-PCI Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content